Asuman Özgöz

Dr. Asuman Özgöz


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2017 in Pathology and Oncology Research
Verified
Journal Article
Closed access
PDF file
AÖAsuman Özgöz
Asuman Özgöz
KÖKuyaş Hekimler Öztürk
Kuyaş Hekimler Öztürk
AYAyşegül Yükseltürk
Ayşegül Yükseltürk
HŞHale Şamlı
Hale Şamlı
ZBZuhal Başkan
Zuhal Başkan
MBMehmet Bacaksız
Mehmet Bacaksız

7 February 2020 in Journal of Genetics
Verified
Journal Article
Closed access
PDF file
AÖAsuman Özgöz
Asuman Özgöz
FİFadİme Mutlu İçduygu
Fadİme Mutlu İçduygu
AYAyşegül Yükseltürk
Ayşegül Yükseltürk
HŞHale Şamli
Hale Şamli
KÖKuyaş Hekİmler Öztürk
Kuyaş Hekİmler Öztürk
ZBZuhal Başkan
Zuhal Başkan

5 October 2021 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
FIfadime mutlu icduygu
fadime mutlu icduygu
HSHale Samli
Hale Samli
AÖAsuman Özgöz
Asuman Özgöz
BVBuse Vatansever
Buse Vatansever
KOKuyas Hekimler Ozturk
Kuyas Hekimler Ozturk
EAEgemen Akgun
Egemen Akgun
Background. Drug resistance poses a crucial problem in the treatment of prostate cancer. Recent studies have shown that chemotherapy agents may cause cancer cells to acquire stem cell-like properties, resulting in drug resistance and, eventually, treatment failure. Objectives. To evaluate whether long-term paclitaxel exposure causes an increase in the stem cell-like properties of prostate cancer cells. Materials and methods. Paclitaxel-resistant PC-3 cells were generated from parental PC-3 cells by treating them with increasing concentrations of paclitaxel. The expression levels of the stem cell markers NANOG, C-MYC, CD44, and ABCG2 were evaluated using quantitative real-time polymerase chain reaction (RT-qPCR). A sphere formation assay was performed to test the potential of the cells to behave as stem cells, and a wound healing assay was carried out to evaluate migration ability of the cells. Results. The expression levels of C-MYC and NANOG were significantly higher in paclitaxel-resistant PC-3 cells compared to the parental PC-3 cells. However, there was no significant increase in the expression of CD44 or ABCG2. In addition, the sphere-forming capacity and migration ability of resistant PC-3 cells were increased. Conclusions. The results of the current study indicate that paclitaxel exposure may increase the stem cell-like properties of PC-3 prostate cancer cells.

21 July 2023 in Medicine
Verified
Journal Article
Open access
FIfadime mutlu icduygu
fadime mutlu icduygu
EAEgemen Akgun
Egemen Akgun
AÖAsuman Özgöz
Asuman Özgöz
KOKuyas Hekimler Ozturk
Kuyas Hekimler Ozturk
DSDemet Sengul
Demet Sengul
EAEbru Alp
Ebru Alp
Long noncoding RNAs (lncRNAs) play an important role in regulating gene expression. Changes in their expression have been associated with many types of cancer, including thyroid cancer. This study aimed to investigate how changes in the expression of potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1 ( KCNQ1OT1 ) and HAGLR opposite strand lncRNA ( HAGLROS ) lncRNAs correlate with the development and clinicopathological characteristics of papillary thyroid cancer (PTC). Reverse transcription-quantitative polymerase chain reaction was used to investigate the expression of lncRNAs in both tumor and adjacent normal thyroid tissue samples of the patients. Expressions of KCNQ1OT1 and HAGLROS were upregulated in the patients tumor samples compared to the adjacent normal thyroid samples. KCNQ1OT1 expression was linked to microcarcinoma and gender, while HAGLROS expression was linked to microcarcinoma and tumor size. When only microcarcinoma samples were evaluated, KCNQ1OT1 expression was higher in tumor tissues compared to normal tissues; however, no significant difference was observed in HAGLROS expression. Our data suggests that high expressions of KCNQ1OT1 and HAGLROS might contribute to the development of PTC and disease progression, and both lncRNAs may be potential therapeutic targets in PTC patients.

23 March 2022 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
KÖKuyaş Hekımler Öztürk
Kuyaş Hekımler Öztürk
FIfadime mutlu icduygu
fadime mutlu icduygu
AÖAsuman Özgöz
Asuman Özgöz
AÖAlper Özorak
Alper Özorak
Objectives: This study aimed to examine the role of miR-221, miR-650, and miR-4534 expressions in the development, pathogenesis, and early diagnosis of prostate cancer. Methods: The study included 83 participants: 37 patients with PCa, 31 patients with BPH, and 15 healthy subjects. MiRNA expressions in plasma samples was evaluated by quantitative RT-PCR. Results: Plasma miR-221 and miR-4534 levels were significantly upregulated in the PCa and BPH groups compared to the control group. A significant difference was determined between the presence of lymph node metastasis and the expressions of miRNAs. In the ROC analysis of the miRNAs, it was determined that the AUC for miR-221 was 0.737 with a sensitivity of 57% and specificity of 100%, AUC for miR-650 was 0.706 with a sensitivity of 62% and specificity of 93% and AUC for miR-4534 was 0.800 with a sensitivity of 73% and specificity of 93%. Conclusions: Overexpression of miR-221, miR-650, and miR-4534 may distinguish PCa and BPH from healthy controls, but seems to be insufficient in differentiating PCa from BPH when used alone or in combination. However, these oncogenic miRNAs may have a role in determining the development and progression of the disease by suppressing the tumor suppressor genes they target.

5 July 2021 in EXCLI Journal
Verified
Journal Article
Open access
AÖAsuman Özgöz
Asuman Özgöz
FIfadime mutlu icduygu
fadime mutlu icduygu
AYAyşegül Yükseltürk
Ayşegül Yükseltürk
HŞHale Şamli
Hale Şamli
KÖKuyaş Hekimler Öztürk
Kuyaş Hekimler Öztürk
ITİlKnur Tütüncü
İlKnur Tütüncü
Obesity is one of the most important health risks in postmenopausal women. Molecular pathways that are connected with obesity are believed to interact with the pathogenesis of breast cancer (BC). The aim of this research was to study the polymorphisms of two obesity-associated genes ADIPOQ and FTO that are also related to the pathogenesis of BC. Obesity-associated gene polymorphisms ADIPOQ rs1501299 and rs2241766, and FTO rs1477196, rs7206790, rs8047395, and rs9939609 were studied in 101 Turkish postmenopausal estrogen receptor-positive BC patients and 100 healthy control individuals. ADIPOQ rs1501299 was detected to be associated with protection against BC. The ADIPOQ rs1501299 TT genotype, the rs2241766 GT genotype and the G allele were found to be significantly higher in the control group. In addition, ADIPOQ rs1501299 polymorphism was protective in the recessive model and rs2241766 polymorphism was protective in the dominant model. While none of the FTO gene polymorphisms were found to be associated with BC, the frequencies of rs9939609 A allele and rs7206790 G allele were correlated with body mass index (BMI) in BC patients. ADIPOQ rs1501299 TT genotype, rs2241766 GT genotype, and G allele might be protective against BC in the Turkish population but this conclusion needs to be further verified.